top
Search terms
Results 1 - 10 of 23 - ordered by :
Pages: 1 2 3
Escardio

BARCELONA, Spain – Monday 1 September: Regulation of the autonomic nervous system with a device that delivers continuous, low-amplitude stimulation to the vagus nerve can significantly improve ...

Date : 01/09/2014
Escardio

In three sessions, breakthroughs in clinical heart failure research will be presented from international trials, meta-analyses and registries including: • TITRATE • STOP-HF • QUALIFY ...

Date : 28/04/2015
Escardio

EUROECHO 2008 is the twelfth Annual Meeting of the European Association of Echocardiography, a registered branch of the European Society of Cardiology Professor Zamorano, from the San Carlos ...

Date : 05/12/2008
Escardio

The MORE-CRT (More Options available with a quadripolar LV lead pRovidE in-clinic solutions to CRT challenges) trial “demonstrates the safety and efficiency of the quadripolar lead technology ...

Date : 30/08/2014
Escardio

Sophia Antipolis, 16 May 2013: A packed programme is promised for EHRA EUROPACE 2013 meeting, taking place in Athens, Greece, 23 to 26 June, with the results of ten late breaking clinical trials and ...

Date : 16/05/2013
Escardio

The European cardiac resynchronization therapy (CRT) Survey is a joint initiative taken by the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of ...

Date : 01/09/2009
Escardio

Emerging cardiac imaging technologies are now sensitive enough to detect early signals of cardiovascular risk. “The concept of a ‘damage clock’ is important in cancer ...

Date : 09/11/2015
Escardio

BARCELONA, Spain – Monday 1 September: In heart failure patients undergoing cardiac resynchronisation therapy (CRT), right ventricular (RV) lead placement in the mid-septum as compared to the ...

Date : 01/09/2014
Escardio

Greater emphasis than ever before has been placed on a practical ‘how to’ approach targeted at generalists, including GPs and geriatricians, as well as expert cardiologists and electro ...

Date : 25/06/2013
Escardio

Drug treatment for chronic heart failure (HF) is acceptable but device implantations are still too low, according to the latest findings of ESC Heart Failure Long-Term Registry. Professor Maggioni ...

Date : 03/09/2013